Variant report
Variant | nsv945300 |
---|---|
Chromosome Location | chr1:220621462-220622701 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:28)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:28 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr1:220621626-220621888 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | BHLHE40 | chr1:220621615-220621951 | GM12878 | blood: | n/a | n/a |
3 | CHD2 | chr1:220621593-220621692 | GM12878 | blood: | n/a | n/a |
4 | CTCF | chr1:220622103-220622129 | GM13977 | blood: | n/a | n/a |
5 | CTCF | chr1:220622053-220622122 | GM20000 | blood: | n/a | n/a |
6 | E2F6 | chr1:220621525-220622012 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | EBF1 | chr1:220621520-220621876 | GM12878 | blood: | n/a | n/a |
8 | EP300 | chr1:220621713-220621913 | GM12878 | blood: | n/a | n/a |
9 | MAX | chr1:220621707-220621931 | GM12878 | blood: | n/a | n/a |
10 | MAX | chr1:220621695-220621895 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | NFE2 | chr1:220621705-220621873 | GM12878 | blood: | n/a | n/a |
12 | NFYA | chr1:220621688-220621853 | GM12878 | blood: | n/a | n/a |
13 | NFYB | chr1:220621648-220621968 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr1:220621731-220621850 | GM12878 | blood: | n/a | n/a |
15 | RUNX3 | chr1:220621545-220621880 | GM12878 | blood: | n/a | n/a |
16 | USF1 | chr1:220621578-220621909 | H1-hESC | embryonic stem cell: | n/a | chr1:220621767-220621778 |
17 | USF1 | chr1:220621662-220621953 | H1-hESC | embryonic stem cell: | n/a | chr1:220621767-220621778 |
18 | USF1 | chr1:220621674-220621887 | SK-N-SH_RA | brain: | n/a | chr1:220621767-220621778 |
19 | USF1 | chr1:220621571-220621958 | HCT-116 | colon: | n/a | chr1:220621767-220621778 |
20 | USF1 | chr1:220621635-220621882 | GM12878 | blood: | n/a | chr1:220621767-220621778 |
21 | USF1 | chr1:220621683-220621862 | HepG2 | liver: | n/a | chr1:220621767-220621778 |
22 | USF1 | chr1:220621599-220621935 | SK-N-SH | brain: | n/a | chr1:220621767-220621778 |
23 | USF1 | chr1:220621634-220621942 | K562 | blood: | n/a | chr1:220621767-220621778 |
24 | USF1 | chr1:220621696-220621861 | GM12878 | blood: | n/a | chr1:220621767-220621778 |
25 | USF2 | chr1:220621580-220622022 | GM12878 | blood: | n/a | chr1:220621767-220621778 |
26 | USF2 | chr1:220621685-220621933 | Hela-S3 | cervix: | n/a | chr1:220621767-220621778 |
27 | USF2 | chr1:220621661-220621854 | H1-hESC | embryonic stem cell: | n/a | chr1:220621767-220621778 |
28 | ZNF143 | chr1:220621596-220621917 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000235163 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150221172 | chr1:220621484-220621485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547118540 | chr1:220621491-220621492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538434799 | chr1:220621509-220621510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184445058 | chr1:220621521-220621522 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs552547858 | chr1:220621546-220621547 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs569541737 | chr1:220621611-220621612 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs531775260 | chr1:220621615-220621616 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs548785094 | chr1:220621618-220621619 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs75572368 | chr1:220621634-220621635 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs138871753 | chr1:220621637-220621638 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs536399127 | chr1:220621677-220621678 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs554350584 | chr1:220621709-220621710 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs149409231 | chr1:220621744-220621745 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs6672068 | chr1:220621750-220621751 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs554258285 | chr1:220621755-220621756 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs73092281 | chr1:220621762-220621763 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs188756435 | chr1:220621769-220621770 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs376890347 | chr1:220621782-220621783 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs555120873 | chr1:220621792-220621793 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs193037610 | chr1:220621805-220621806 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs200044000 | chr1:220621808-220621809 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs200838881 | chr1:220621822-220621823 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs563841819 | chr1:220621939-220621940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73092282 | chr1:220621942-220621943 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs543420859 | chr1:220621949-220621950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563010009 | chr1:220622003-220622004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185731234 | chr1:220622042-220622043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116762162 | chr1:220622050-220622051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs111659440 | chr1:220622052-220622053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372924097 | chr1:220622062-220622063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527937639 | chr1:220622095-220622096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547866547 | chr1:220622096-220622097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188991568 | chr1:220622105-220622106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539419218 | chr1:220622116-220622117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1856434 | chr1:220622247-220622248 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs376715924 | chr1:220622309-220622310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569978216 | chr1:220622316-220622317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535724937 | chr1:220622367-220622368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1338774 | chr1:220622393-220622394 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs571861168 | chr1:220622429-220622430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12408337 | chr1:220622474-220622475 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs181072236 | chr1:220622480-220622481 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1572686 | chr1:220622491-220622492 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs539640891 | chr1:220622557-220622558 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200282846 | chr1:220622562-220622563 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184140540 | chr1:220622601-220622602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563277274 | chr1:220622611-220622612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2153130 | chr1:220622671-220622672 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Autism | 14699429 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:220610000-220624000 | Weak transcription | Fetal Heart | heart |
2 | chr1:220617600-220622400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr1:220620400-220624400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr1:220620600-220626800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
5 | chr1:220621000-220622200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr1:220621200-220624600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr1:220621400-220622200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr1:220622200-220624600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr1:220622200-220624800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr1:220622400-220623000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr1:220622600-220623000 | Enhancers | H1 Cell Line | embryonic stem cell |